NeoDynamics AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEOD.ST research report →
Companywww.neodynamics.se
NeoDynamics AB (publ), a medical technology company, develops biopsy system to enhance diagnosis and care of breast cancer patients. It develops NeoNavia, a precision biopsy system that offers clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. The company was incorporated in 2015 and is based in Lidingö, Sweden.
- CEO
- Matthew E. Colpoys Jr.
- IPO
- 2018
- Employees
- 13
- HQ
- Lidingö, SE
Price Chart
Valuation
- Market Cap
- $29.35M
- P/E
- -0.03
- P/S
- 91.43
- P/B
- 0.07
- EV/EBITDA
- -0.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -28323.99%
- Op Margin
- -28323.99%
- Net Margin
- -28867.60%
- ROE
- -147.47%
- ROIC
- -214.29%
Growth & Income
- Revenue
- $321.00K · 137.96%
- Net Income
- $-92,665,000 · -24.36%
- EPS
- $-30.21 · 51.27%
- Op Income
- $-90,920,000
- FCF YoY
- -16.54%
Performance & Tape
- 52W High
- $19.06
- 52W Low
- $0.71
- 50D MA
- $0.92
- 200D MA
- $1.44
- Beta
- 1.24
- Avg Volume
- 44.59K
Get TickerSpark's AI analysis on NEOD.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NEOD.ST Coverage
We haven't published any research on NEOD.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NEOD.ST Report →